<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>drug approval &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/drug-approval/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Oct 2026 16:14:26 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>drug approval &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Canada&#8217;s new reliance rule for foreign drug approvals may not fix pediatric shortages</title>
		<link>https://bioengineer.org/canadas-new-reliance-rule-for-foreign-drug-approvals-may-not-fix-pediatric-shortages/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 26 Oct 2026 16:14:26 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[drug approval]]></category>
		<category><![CDATA[drug incentives]]></category>
		<category><![CDATA[European Medicines Agency]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Health Canada]]></category>
		<category><![CDATA[Health Policy]]></category>
		<category><![CDATA[Ministerial Order]]></category>
		<category><![CDATA[off-label use]]></category>
		<category><![CDATA[pediatric drugs]]></category>
		<category><![CDATA[pediatric formulations]]></category>
		<category><![CDATA[regulatory reliance]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=454529</guid>

					<description><![CDATA[A new analysis argues that Canada's Ministerial Order allowing reliance on foreign regulatory decisions may speed approvals but lacks the mandatory requirements and incentives that made pediatric drug reform successful in the United States and Europe.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">454529</post-id>	</item>
	</channel>
</rss>
